位置:成果数据库 > 期刊 > 期刊详情页
Osteogenesis of Adipose-Derived Stem Cells
  • 分类:Q811.4[生物学—生物工程] TB39[一般工业技术—材料科学与工程]
  • 作者机构:[1]Department of Orthopaedic Surgery, MassGeneral Hospital for Children and the Pediatric Orthopaedic Laboratory for TissueEngineering and Regenerative Medicine, Harvard Medical School, Boston, Massachusetts, USA
  • 相关基金:This work was funded by National Natural Science Foundation of China (81071273, 31170929), Foundation for the Author of National Excellent Doctoral Dissertation of China (FANEDD 200977), Innovative Research Team of Education Department of Sichuan Province (13TD0038).
中文摘要:

Current treatment options for skeletal repair,including immobilization,rigid fixation,alloplastic materials and bone grafts,have significant limitations.Bone tissue engineering offers a promising method for the repair of bone deficieny caused by fractures,bone loss and tumors.The use of adipose derived stem cells(ASCs) has received attention because of the self-renewal ability,high proliferative capacity and potential of osteogenic differentiation in vitro and in vivo studies of bone regeneration.Although cell therapies using ASCs are widely promising in various clinical fields,no large human clinical trials exist for bone tissue engineering.The aim of this review is to introduce how they are harvested,examine the characterization of ASCs,to review the mechanisms of osteogenic differentiation,to analyze the effect of mechanical and chemical stimuli on ASC osteodifferentiation,to summarize the current knowledge about usage of ASC in vivo studies and clinical trials,and finally to conclude with a general summary of the field and comments on its future direction.

英文摘要:

Current treatment options for skeletal repair, including immobilization, rigid fixation, alloplastic materials and bone grafts, have significant limitations. Bone tissue engineering offers a promising method for the repair of bone deficieny caused by fractures, bone loss and tumors. The use of adipose derived stem cells (ASCs) has received attention because of the self-renewal ability, high proliferative capacity and potential of osteogenic differentiation in vitro and in vivo studies of bone regeneration. Although cell therapies using ASCs are widely promising in various clinical fields, no large human clinical trials exist for bone tissue engineering. The aim of this review is to introduce how they are harvested, examine the characterization of ASCs, to review the mechanisms of osteogenic differentiation, to analyze the effect of mechanical and chemical stimuli on ASC osteodifferentiation, to summarize the current knowledge about usage of ASC in vivo studies and clinical trials, and finally to conclude with a general summary of the field and comments on its future direction.

同期刊论文项目
期刊论文 27 会议论文 2 获奖 5 著作 2
同项目期刊论文